• Group
    • Companies
    • History
    • Business model
    • Mission and vision
    • Corporate values
    • Commitment to sport
  • Research
    • Pharmaceutical Research
    • Sucrosomial Technology
    • Cetylated Fatty Acids
    • Quality and certifications
  • Brands
    • PharmaNutra
      • SiderAL
      • SiderAL Forte
      • SiderAL Folico
      • Cardio SiderAL
      • SiderAL Med
      • Cetilar Crema
      • Cetilar Patch
      • Cetilar Tape
      • Cetilar Oro
      • ApportAL
      • UltraMag
      • Gestalys DHA
      • Novomega
      • Bonecal
      • DiKappa2
    • Junia Pharma
    • Alesco
    • Akern
  • Investor
    • INVESTOR RELATIONS
      • Stock performance
      • Share capital and Shareholders
      • Shares study and research
      • Broker
      • Financial statements
      • Presentations
      • Corporate events
      • Company presentation
      • Notice of meetings
      • SDIR
      • AIM admission document
      • MTA prospectus
    • PRESS
      • Press releases
      • Press review
  • Governance
    • Code of Ethics
    • 231 Model
    • Board of Directors and Committees
    • Company documents
    • Internal dealing
    • Shareholders’ meeting
    • Statutory auditors and Audit firm
    • Sharholders Agreements
  • Sustainability
  • News
    • Science
    • Corporate
    • Events
    • Social commitment
  • Careers
    • Work with us
    • Job offers
    • Job application
  • Group
    • Companies
    • History
    • Business model
    • Mission and vision
    • Corporate values
    • Commitment to sport
  • Research
    • Pharmaceutical Research
    • Sucrosomial Technology
    • Cetylated Fatty Acids
    • Quality and certifications
  • Brands
    • PharmaNutra
      • SiderAL
      • SiderAL Forte
      • SiderAL Folico
      • Cardio SiderAL
      • SiderAL Med
      • Cetilar Crema
      • Cetilar Patch
      • Cetilar Tape
      • Cetilar Oro
      • ApportAL
      • UltraMag
      • Gestalys DHA
      • Novomega
      • Bonecal
      • DiKappa2
    • Junia Pharma
    • Alesco
    • Akern
  • Investor
    • INVESTOR RELATIONS
      • Stock performance
      • Share capital and Shareholders
      • Shares study and research
      • Broker
      • Financial statements
      • Presentations
      • Corporate events
      • Company presentation
      • Notice of meetings
      • SDIR
      • AIM admission document
      • MTA prospectus
    • PRESS
      • Press releases
      • Press review
  • Governance
    • Code of Ethics
    • 231 Model
    • Board of Directors and Committees
    • Company documents
    • Internal dealing
    • Shareholders’ meeting
    • Statutory auditors and Audit firm
    • Sharholders Agreements
  • Sustainability
  • News
    • Science
    • Corporate
    • Events
    • Social commitment
  • Careers
    • Work with us
    • Job offers
    • Job application
  • it
  • en

Internal dealing

  • INTERNAL DEALING 21/12/2021 RLH SRL
  • INTERNAL DEALING 21/12/2021 ALH SRL
  • INTERNAL DEALING 21/12/2021 ROBERTO LACORTE
  • INTERNAL DEALING 21/12/2021 ANDREA LACORTE
  • INTERNAL DEALING 23/09/2020 BEDA SRL – CARLO VOLPI
  • INTERNAL DEALING 23/09/2020 ROBERTO LACORTE
  • INTERNAL DEALING 23/09/2020 ANDREA LACORTE
  • INTERNAL DEALING 16/04/2019 ROBERTO LACORTE
  • INTERNAL DEALING 16/04/2019 ANDREA LACORTE
  • INTERNAL DEALING 16/04/2019 GIANNI LAZZARINI
  • INTERNAL DEALING 16/04/2019 BEDA SRL CARLO VOLPI
  • INTERNAL DEALING 08/10/2018 ROBERTO LACORTE
  • INTERNAL DEALING 09/10/2018 ANDREA LACORTE
  • INTERNAL DEALING BEDA SRL CONVERSIONE PAS 19/10/2017
  • INTERNAL DEALING LAZZARINI GIANNI CONVERSIONE PAS 19/10/2017
  • INTERNAL DEALING TARANTINO GERMANO CONVERSIONE PAS 19/10/2017
  • INTERNAL DEALING LACORTE ROBERTO CONVERSIONE PAS 19/10/2017
  • INTERNAL DEALING LACORTE ANDREA CONVERSIONE PAS 19/10/2017
  • INTERNAL DEALING 07/12/2017 BEDA SRL
  • INTERNAL DEALING 07/12/2017 LAZZARINI GIANNI
  • INTERNAL DEALING 07/12/2017 TARANTINO GERMANO
  • INTERNAL DEALING 07/12/2017 LACORTE ROBERTO
  • INTERNAL DEALING 07/12/2017 LACORTE ANDREA

PharmaNutra Spa

Registered office

Via Delle Lenze, 216/b - 56122 Pisa

Phone +39 050 7846500

Fax +39 050 7846524

Electronic billing code

SUBM70N

C.F. / P.Iva / Reg. Impr. 01679440501

Share capital € 1.123.097,70

I.V. | REA 146259

Contacts

Info
info@pharmanutra.it
Commerciale
commerciale@pharmanutra.it
Investor relations
investorrelation@pharmanutra.it
Distribution
internationaldept@pharmanutra.it

Product sites

sideral.it

cetilar.it

ultramag.it

apportal.it

NEWSLETTER

Subscribe to the Pharmanutra newsletter and you will be constantly updated on all our activities.
Read Newsletter Disclosure

Subscribe to the newsletter
Privacy & Cookie policy Change cookie preferences General conditions PRIVACY INFORMATION FOR CUSTOMERS

© 2023 2020 PharmaNutra SpA - All rights reserved

Modifica preferenze Cookie
Modifica preferenze Cookie